Important Safety Information: Contraindications: CERDELGA is contraindicated in the following patients based on CYP2D6 metabolizer status due to the risk of cardiac arrhythmias from prolongation of the PR, QTc, and/or QRS cardiac intervals: Extensive Metabolizers (EMs) taking a strong or moderate CYP2D6 inhibitor concomitantly with a strong or... View more

Request a Cerdelga Representative

A Cerdelga sales representative may be able to assist you in obtaining disease information, product information, and samples.

Please call 1‑800‑745‑4447, Option 5 or complete the form below. The information you provide will be maintained in accordance with our Privacy Policy.

All fields required.